LUMIFY® Redness Reliever Eye Drops (Brimonidine Tartrate Ophthalmic Solution 0.025%) – from Bausch + Lomb, 0.25 Fl. Oz. (7.5 mL) by CWEB Reviews

LUMIFY eye drops significantly reduce redness to help eyes appear whiter, brighter, and more radiant. LUMIFY is a unique, FDA approved formulation, that was developed by doctors and is clinically proven to reduce redness in 1 minute and last up to 8 hours. LUMIFY works differently to selectively target redness with a lower risk of potential side effects. Contains absolutely no bleach or dyes.

Special Discount BUY @ Walmart

  • EYE DROPS FOR RED EYES: LUMIFY redness reliever eye drops significantly reduce redness to help reveal your eyes’ natural radiance. From the eye care experts at Bausch + Lomb, LUMIFY works in 1 minute & lasts up to 8 hours.
  • LUMIFY IS DIFFERENT: LUMIFY eye drops are one of a kind. LUMIFY is the only over-the-counter drop that contains the active ingredient brimonidine, which works to selectively target redness, alleviating some of the potential side effects associated with other redness relievers, when used as directed.
  • FDA APPROVED: LUMIFY contains no bleach or dyes and is FDA approved. LUMIFY eye drops significantly reduce redness to help eyes appear whiter, brighter, and more radiant. It’s the #1 Eye Doctor recommended redness reliever (based on IQVIA survey)
  • WHAT CAUSES EYE REDNESS? Eye redness, unrelated to infection or injury, is a common condition that can be caused by eye fatigue, dryness or dust, overexposure to the sun, allergies, swimming in chlorinated pools, or contact lenses.
  • AMAZING LOOKING EYES: We understand how important eyes are. And despite all the eye creams, mascara, eye-liners and shadows, if your eyes are red, you won’t look your best.
We aim to show you accurate product information. Manufacturers, suppliers and others provide what you see here, and we have not verified it.
Special Discount BUY @ Walmart
(Photo: Walmart)

Follow us on Google news for more updates and News


Full Disclaimer








>

FREE

Get the most important news and analyses for Free.

Thank you for subscribing.

Something went wrong.